Rohit Kashyap, M.D.

David Pai, M.D.
Address:

1111 Exposition Blvd., Suite 300
Sacramento, CA 95815
Ph: 916-564-6232
Fax: 916-564-6242

333 University Av., Suite 120
Sacramento, CA 95825
916 929-8564

Position:
  • Interventional & Clinical Nephrologist
  • Capital Nephrology Access Center
  • Capital Nephrology Medical Group
Nephrology Fellowship:
  • Ohio State University Medical Center, Columbus, Ohio
    July 2006 to June 2008
Internship and Residency:
  • Wright State University, Internal Medicine, Dayton, Ohio
    Chief Resident in final year of residency
    July 1996 to June 1999
Licensure and Certification:
  • California, Ohio, West Virginia (inactive)
  • Board Certified in Internal Medicine
    1999-2009
  • Board Eligible in Nephrology
    2008-2018
Medical School:
  • University College of Medical Sciences, Delhi, India
    June 1989 to January 1995
Work Experience:
  • International Nephrologist - Capital Nephrology Medical Group, Sacramento
    Since July 2008 - Present
  • Hospitalist - Ohio State University Hospitals East, Columbus, Ohio
    June 2003 to June 2006
  • Internist - Holzer Medical Center and Holzer Family Care Center, Jackson, Ohio
    August 2001 to May 2003
  • Internist - Veterans Memorial Hospital and Clinic, Pomeroy, Ohio
    October 1999 to July 2001 (closed in July 2001)
Appointments:
  • Medical Director- DaVita North Sacramento Dialysis Clinic – Present
Hospital Affiliations:
  • Mercy General Hospital
  • Mercy San Juan Hospital
  • Mercy Folsom Hospital
  • Methodist Hospital
  • Woodland Memorial Hospital
  • Marshall Hospital
  • Sutter Community Hospital
  • Sutter Davis Hospital
Clinical Participation:

February 2011: BPV-08-002 – Prospective, Multi-Center, Randomized, Concurrently-Controlled Study of the Fluency® Plus Endovascular Stent Graft in the Treatment of In-Stent Restenosis in the AV Access Venous Outflow Circuit (RESCUE)
Sponsor: Bard Peripheral Vascular, Inc.
Naveen Atray, MD as PI, Rohit Kashyap, MD as sub-investigator

March 2011: QWC01-MN-01 – A Randomized, Placebo-Controlled, Double-Blind Study of H.P. Acthar® Gel (Acthar) in Treatment-Resistant Subjects with Persistent Proteinuria and Nephrotic Syndrome due to Idiopathic Membranous Nephropathy (iMN)
Sponsor: Questcor Pharmaceuticals, Inc.; Naveen Atray, MD as PI; Elena Gelfand, MD, Ratnaji Nallamothu, MD, Matthew Mezger, MD, David Pai, MD and Rohit Kashyap, MD as sub-investigators

October 2012: CTAP101-CL-3001 – A Multi-Center, Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Efficacy and Safety of CTAP101 Capsules to Treat Secondary Hyperparathyroidism in Subjects with Stage 3 or 4 Chronic Kidney Disease and Vitamin D Insufficiency
Sponsor: Cytochroma, Inc.; Naveen Atray, MD as PI; Elena Gelfand, MD, Ratnaji Nallamothu, MD, Matthew Mezger, MD, David Pai, MD and Rohit Kashyap, MD as sub-investigators

December 2012: ZS -003 – A Phase 3 Multicenter, Two-Phase, Multi-Dose, Prospective, Randomized, Double-Blind, Placebo-Controlled Study to Investigate the Safety and Efficacy of ZS (Microporous, Fractionated, Protonated Zirconium Silicate), an Oral Sorbent, in Subjects with Mild to Moderate Hyperkalemia
Sponsor: ZS Pharma, Inc.; Naveen Atray, MD as PI; Elena Gelfand, MD, Ratnaji Nallamothu, MD, Matthew Mezger, MD, David Pai, MD and Rohit Kashyap, MD as sub-investigators

April 2013: D5611C00001 – A Phase 2a, Randomized, Double-Blind, Placebo-Controlled, Parallel Design Study to Evaluate the Pharmacodynamics, Safety and Tolerability of AZD1722 in End Stage Renal Disease Patients on Hemodialysis
Sponsor: Ardelyx, Inc.; Naveen Atray, MD as PI; Ratnaji Nallamothu, MD and Rohit Kashyap, MD as sub-investigators

Our Locations

CNMG

Capital Nephrology Medical Group

333 University Av., Suite 120

Sacramento, CA 95825

Tel: 916-929-8564

Fax: 916-929-4529



View Office Locations in a larger map

We care about your and your family members' health and helping you make wise care decisions.

Understanding what kind of care you and your family members need is important.

If you think you or your family member has a medical or psychiatric emergency, call 911 or go to the nearest hospital. Do not attempt to access emergency care through this website.